PNC Financial Services Group Inc. Lowers Holdings in iShares Biotechnology ETF (NASDAQ:IBB)

PNC Financial Services Group Inc. lowered its holdings in iShares Biotechnology ETF (NASDAQ:IBB) by 2.8% during the third quarter, Holdings Channel.com reports. The firm owned 358,192 shares of the financial services provider’s stock after selling 10,473 shares during the period. PNC Financial Services Group Inc.’s holdings in iShares Biotechnology ETF were worth $52,153,000 at the end of the most recent quarter.

Other large investors have also modified their holdings of the company. Williams Financial LLC acquired a new position in shares of iShares Biotechnology ETF in the 2nd quarter worth approximately $867,000. PVG Asset Management Corp acquired a new position in iShares Biotechnology ETF during the second quarter worth $415,000. Huntington National Bank boosted its position in shares of iShares Biotechnology ETF by 17.9% during the third quarter. Huntington National Bank now owns 1,054 shares of the financial services provider’s stock worth $153,000 after buying an additional 160 shares during the period. Concourse Financial Group Securities Inc. boosted its position in shares of iShares Biotechnology ETF by 22.4% during the second quarter. Concourse Financial Group Securities Inc. now owns 656 shares of the financial services provider’s stock worth $90,000 after buying an additional 120 shares during the period. Finally, Raymond James & Associates grew its stake in shares of iShares Biotechnology ETF by 4.4% in the second quarter. Raymond James & Associates now owns 189,766 shares of the financial services provider’s stock valued at $26,047,000 after buying an additional 7,931 shares in the last quarter. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Price Performance

IBB opened at $134.84 on Thursday. The stock’s 50-day moving average price is $143.82 and its 200 day moving average price is $141.75. iShares Biotechnology ETF has a 12-month low of $117.28 and a 12-month high of $150.57.

iShares Biotechnology ETF Dividend Announcement

The firm also recently declared a dividend, which was paid on Monday, September 30th. Stockholders of record on Wednesday, September 25th were given a dividend of $0.2005 per share. The ex-dividend date was Wednesday, September 25th.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.